相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
Simonetta M. Leto et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy
Francesca Carlomagno et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
Arjan Gower et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic
Alessandra Fabi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
分享论文
